Incyte Corp
(BSP:I1NC34)
R$
221.1
0 (0%)
Market Cap: 85.19 Bil
Enterprise Value: 75.12 Bil
PE Ratio: 541.07
PB Ratio: 4.61
GF Score: 77/100 Incyte Corp at Bank of America Global Research Healthcare Conference (Virtual) Transcript
May 13, 2021 / 04:30PM GMT
Release Date Price:
R$235
Tazeen Ahmad
BofA Securities, Research Division - VP
My pleasure to have my next presenting company with me for the next half hour, Incyte. Presenting from Incyte this afternoon will be Steve Stein, who is of course Chief Medical Officer; as well as Christiana Stamoulis, who is Chief Financial Officer. Steve and Christiana, good afternoon.
Christiana Stamoulis
Incyte Corporation - Executive VP & CFO
Thank you for having us.
Steven H. Stein
Incyte Corporation - Executive VP & Chief Medical Officer
Thank you.
Tazeen Ahmad;Christiana Stamoulis
BofA Securities, Research Division - VP;Incyte
So there probably are very few people who don't know that much about Incyte, but on the off chance that we have some people on this webcast that don't know the story quite as well. Maybe could we ask you to give a 2-minute or less overview of the company and the platform and then we can go into some more specific questions if that's okay.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot